ClinicalTrials.Veeva

Menu

CP4ACS - Delphi Study to Determine Appropriateness of STEMI Quality Indicators in Belgium

E

European Pathway Association

Status

Completed

Conditions

Quality Indicators
STEMI

Study type

Observational

Funder types

Other

Identifiers

NCT02030210
CP4ACS\2013\1

Details and patient eligibility

About

RAND/UCLA modified Delphi study on quality indicators for STEMI to determine the appropriateness of quality indicators retrieved from literature and guideline review. We aim to engage 20 cardiologists and 20 nurses with relevant experience in the care for STEMI patients.

Enrollment

32 patients

Sex

All

Ages

18 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • cardiologist or cardio nurse with relevant experience in the care for STEMI patients

Exclusion criteria

Trial design

32 participants in 3 patient groups

cardiologists
study coordinators
registred nurses

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems